Properties
Description
ARP 100 inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9.
Molecular Formula
C17H20N2O5S
Targets
MMP-1: >50 μM; MMP-2: 12 nM; MMP-3: 4.5 μM; MMP-7: >50 μM; MMP-9: 0.2 μM
Identity
Confirmed by NMR/HPLC/MS.
Applications
ARP 100 is used to inhibit matrix metalloproteinases, which degrade components of the extracellular matrix, serving as a potential therapeutic target in cancer and arthritis research.
